The US Food and Drug Administration has approved a pill version of the weight-loss drug Wegovy, according to maker Novo Nordisk.

It marks a first in this new era of weight-loss medications with Wegovy being the only so far to gain approval for the pill version of their GLP-1 drug, which has only been available as an injection.

Wegovy’s Danish makers Novo Nordisk said the once-daily pill was a “convenient option” to the inject-able and would provide the same weight loss as the shot. It comes after Wegovy was approved by the FDA specifically for weight loss.

Others like Ozempic, which has similar weight-loss effects, were primarily approved for the treatment of Type 2 diabetes.